Please log in to view this page
Username
Password
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
